Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 From the analyst's couch: Next-generation antibodies.

× No keyword cloud information.

1 in total

1. Which are the antibodies to watch in 2013?

Authors: Janice M Reichert
Journal: MAbs Date: 2012-12-19 Impact factor: 5.857

1 in total

14 in total

1. Viscosity Analysis of Dual Variable Domain Immunoglobulin Protein Solutions: Role of Size, Electroviscous Effect and Protein-Protein Interactions.

Authors: Ashlesha S Raut; Devendra S Kalonia
Journal: Pharm Res Date: 2015-08-19 Impact factor: 4.200

2. A fluorescent imaging method for analyzing the biodistribution of therapeutic monoclonal antibodies that can distinguish intact antibodies from their breakdown products.

Authors: Takuo Suzuki; Chihiro Miyazaki; Akiko Ishii-Watabe; Minoru Tada; Kumiko Sakai-Kato; Toru Kawanishi; Nana Kawasaki
Journal: MAbs Date: 2015-04-18 Impact factor: 5.857

Review 3. Vaccinal antibodies: Fc antibody engineering to improve the antiviral antibody response and induce vaccine-like effects.

Authors: Dhuha H Nawab
Journal: Hum Vaccin Immunother Date: 2021-11-29 Impact factor: 3.452

4. Directed evolution of anti-HER2 DARPins by SNAP display reveals stability/function trade-offs in the selection process.

Authors: Gillian Houlihan; Pietro Gatti-Lafranconi; David Lowe; Florian Hollfelder
Journal: Protein Eng Des Sel Date: 2015-06-30 Impact factor: 1.650

5. Bispecific Antibody Conjugated Manganese-Based Magnetic Engineered Iron Oxide for Imaging of HER2/neu- and EGFR-Expressing Tumors.

Authors: Shou-Cheng Wu; Yu-Jen Chen; Hsiang-Ching Wang; Min-Yuan Chou; Teng-Yuan Chang; Shyng-Shiou Yuan; Chiao-Yun Chen; Ming-Feng Hou; John Tsu-An Hsu; Yun-Ming Wang
Journal: Theranostics Date: 2016-01-01 Impact factor: 11.556

6. Disruption of cell adhesion by an antibody targeting the cell-adhesive intermediate (X-dimer) of human P-cadherin.

Authors: Shota Kudo; Jose M M Caaveiro; Satoru Nagatoishi; Takamitsu Miyafusa; Tadashi Matsuura; Yukio Sudou; Kouhei Tsumoto
Journal: Sci Rep Date: 2017-01-03 Impact factor: 4.379

7. High-throughput thermal stability analysis of a monoclonal antibody by attenuated total reflection FT-IR spectroscopic imaging.

Authors: Maxime Boulet-Audet; Bernadette Byrne; Sergei G Kazarian
Journal: Anal Chem Date: 2014-09-26 Impact factor: 6.986

Review 8. Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?

Authors: Yvonne W S Jauw; C Willemien Menke-van der Houven van Oordt; Otto S Hoekstra; N Harry Hendrikse; Danielle J Vugts; Josée M Zijlstra; Marc C Huisman; Guus A M S van Dongen
Journal: Front Pharmacol Date: 2016-05-24 Impact factor: 5.810

9. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for ⁸⁹Zr-immuno-PET.

Authors: Danielle J Vugts; Chris Klaver; Claudia Sewing; Alex J Poot; Kevin Adamzek; Seraina Huegli; Cristina Mari; Gerard W M Visser; Ibai E Valverde; Gilles Gasser; Thomas L Mindt; Guus A M S van Dongen
Journal: Eur J Nucl Med Mol Imaging Date: 2016-08-30 Impact factor: 9.236

Review 10. Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy.

Authors: Juan C Almagro; Tracy R Daniels-Wells; Sonia Mayra Perez-Tapia; Manuel L Penichet
Journal: Front Immunol Date: 2018-01-04 Impact factor: 7.561